伟思医疗
(688580)
| 流通市值：39.95亿 | | | 总市值：39.95亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 226,437,246.19 | 106,040,321.83 | 462,725,664.61 | 325,530,311.85 |
| 营业收入 | 226,437,246.19 | 106,040,321.83 | 462,725,664.61 | 325,530,311.85 |
| 二、营业总成本 | 158,213,887.06 | 74,643,980.57 | 344,480,453.6 | 235,847,318 |
| 营业成本 | 76,288,886.97 | 35,887,302.77 | 156,456,654.82 | 107,877,419.58 |
| 税金及附加 | 2,899,958.22 | 2,485,544.9 | 6,598,119.49 | 4,849,462.71 |
| 销售费用 | 37,741,541.92 | 15,697,981.25 | 91,800,951.92 | 61,113,366.77 |
| 管理费用 | 21,266,657.98 | 10,809,627.29 | 47,361,513.36 | 32,645,201.87 |
| 研发费用 | 21,995,513.42 | 10,780,108.67 | 45,116,123.69 | 31,712,293.48 |
| 财务费用 | -1,978,671.45 | -1,016,584.31 | -2,852,909.68 | -2,350,426.41 |
| 其中:利息费用 | 7,626.44 | 4,836.13 | 1,308,051.09 | 1,050,393.12 |
| 其中:利息收入 | 2,107,405.02 | 1,070,574.96 | 4,212,882.79 | 3,426,329.16 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 4,835,413.96 | - |
| 加:投资收益 | 5,834,397.97 | 2,550,983.42 | 12,533,301.1 | 9,763,745.78 |
| 资产处置收益 | 33,201,910.35 | 32,136,104.12 | -880.57 | -864.63 |
| 资产减值损失(新) | -64,656.8 | - | -430,627.75 | -122,968.26 |
| 信用减值损失(新) | -182,093.98 | 99,626.15 | -835,770.56 | -149,229.7 |
| 其他收益 | 7,656,495.34 | 4,182,167.54 | 17,976,980.19 | 13,437,510.02 |
| 四、营业利润 | 114,669,412.01 | 70,365,222.49 | 152,323,627.38 | 112,611,187.06 |
| 加:营业外收入 | 29,748.79 | 2,213.26 | 2,197,890.44 | 276,467.32 |
| 减:营业外支出 | 383,410.33 | 2,213.94 | 89,857.11 | 13,487.25 |
| 五、利润总额 | 114,315,750.47 | 70,365,221.81 | 154,431,660.71 | 112,874,167.13 |
| 减:所得税费用 | 14,193,030.54 | 8,791,905.02 | 16,359,015.21 | 10,725,879.9 |
| 六、净利润 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 |
| 扣除非经常损益后的净利润 | 67,043,515.85 | 33,065,027.7 | 121,384,115.98 | 93,600,044.21 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.05 | 0.64 | 1.44 | 1.07 |
| (二)稀释每股收益 | 1.05 | 0.64 | 1.44 | 1.07 |
| 九、综合收益总额 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 |
| 归属于母公司股东的综合收益总额 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 |
| 公告日期 | 2026-08-26 | 2026-04-28 | 2026-04-28 | 2025-10-23 |
| 审计意见(境内) | | | 标准无保留意见 | |